Anabolic Steroids Market Size & Share, by Synthetic Derivatives (17 Alpha Alkyl Derivatives, 17 Beta Ester Derivatives); Modes of Administration (Oral, Injection, Topical, Skin Patches, Inhalers); Indication (Anaemia, Breast Cancer, Hypogonadism); Drugs (Oxymetholone, Methyltestosterone, Testosterone); Applications (Anabolic, Androgenic); Distribution Channels (Hospital, Retail, Online) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5986
  • Published Date: Apr 03, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Anabolic Steroids Market size is expected to reach USD 47 Billion by the end of 2036, growing at a CAGR of 10% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of anabolic steroids was USD 15 Billion. As the number of elderly people increases, so does the market for anabolic steroids. People 60 years of age and older will outnumber children under five by 2023.Eighty percent of the elderly worldwide will reside in low- and middle-income nations by 2050. The rate of population aging is far faster than it used to be. Furthermore, the anabolic steroids market is expanding as men's weight issues get worse.

In addition to these, the list of uses for androgens and anabolic steroids may grow in the future. Their potential application in the management of a number of illnesses, including osteoporosis, disorders involving the breakdown of muscle, and several hormone imbalances, is still being investigated. Furthermore, creating new, practical delivery methods for androgens and anabolic steroids like long-acting injectables or transdermal patches can enhance patient compliance and the therapy process as a whole.

Anabolic Steroids Market
Get more information on this report: Request Free Sample PDF

Anabolic Steroids Sector: Growth Drivers and Challenges

Growth Drivers

  • The Prevalence of Hypogonadism in Men is Rising- The growing incidence of hypogonadism in men will drive the anabolic steroids market expansion. It is estimated that between 30 and 50 percent of men with type 2 diabetes or obesity and 35 percent of males over 45 have hypogonadism. A low level of testosterone in males causes hypogonadism, which impairs their quality of life and the function of many organs. The main reasons of male impotence are exhaustion, sleep deprivation, worry, and binge drinking. Breast cancer is the result of women's breast cells developing out of control. These cells develop into a tumor, which appears as an X-ray or can be felt as a bump. The infection of adjacent tissues by these cells leads to malignant malignancy.
  • Infrastructure Spending in the Healthcare Sector is Rising- The increasing cost of healthcare, which contributes to the development of the industry's infrastructure, is another important factor impacting the anabolic steroids market growth rate. Additionally, by boosting funding, a number of government groups hope to strengthen the healthcare infrastructure, which would further alter the dynamics of the market.
  • Growing Popularity Among Youth for Bodybuilding- A primary driver of the anabolic steroid business is the increasing adolescent interest in bodybuilding. The performance-enhancing drug that is used worldwide is called steroids. The rise in athletic events has led to a sharp increase in the demand for steroids, which is good news for the worldwide steroid business. Steroids can promote the growth of facial and pubic hair. It enhances ambition and focus while also deepening the voice. Steroids are therefore advantageous for overly feminine hormones. In the US, an estimated 43% of gym patrons participate in bodybuilding exercises.


  • Long-term usage of steroids might have the following side effects- Use of AAS for extended periods of time may harm the immune system. Elevated blood pressure is a typical side effect of AAS, particularly in people who already have hypertension. According to studies, persons who use steroids regularly are more likely to develop cardiovascular diseases. Acne, seborrhea, excessive body hair development, androgenic alopecia, irregular menstruation, and many more are other related side effects. Thus, improper usage of anabolic steroids might have negative consequences on a person and prevent their progress globally.
  • The overuse and abuse of anabolic steroids, particularly in the context of sports and bodybuilding, is one of the main issues facing this anabolic steroids market.  
  • The usage of anabolic steroids can have a number of harmful health repercussions, including heart disease, liver damage, kidney issues, and mental difficulties. This is especially the case when the steroids are taken for extended periods of time or in excess.

Anabolic Steroids Market: Key Insights

Base Year


Forecast Year



~ 10%

Base Year Market Size (2023)

 ~ USD 15 Billion

Forecast Year Market Size (2036)

 ~ USD 47 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Anabolic Steroids Segmentation

Modes of Administration (Oral, Injection, Topical, Skin Patches, Inhalers)

Based modes of administration, injection segment in the anabolic steroids market is anticipated to hold 45% of the revenue share by 2036. The injections segment is being driven by a number of factors, including high unmet demand, an increase in the frequency of bone & joint problems, government awareness programs for joint disorders, a rise in the number of obese people as a result of unhealthy lifestyles, and favorable health insurance coverage. Globally, the Statistic Brain Research Institute estimates that 50 million people have been diagnosed with arthritis. The global market for steroid injections is also being driven by factors such as growing demand for steroid injections, improvements in steroid injection treatment, and growing health consciousness. About 180 million people in India suffer from arthritis, according to Arthritis-India. The prevalence of many well-known illnesses is higher than this, including cancer, AIDS, and diabetes. With more than 60 million people predicted to be impacted, India is predicted to become the global epicenter for osteoarthritis by 2025. Owing to the quick and efficient results, there is a growing demand for steroid injections, which is driving this anabolic steroids market expansion.

Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Based on distribution channels, online pharmacies segment in the anabolic steroids market is anticipated to hold 40% of the revenue share by 2036. Online sales are expected to rise since manufacturers and distributors are currently leaning toward doing business online. Furthermore, the anabolic steroids market is driven higher by the growing usage of smartphones and the widespread use of social media. Global mobile user count was 7.1 billion in 2021; predictions indicate that by 2022, this figure is expected to increase to 7.26 billion. Global mobile user count is expected to reach 7.49 billion by 2025.

Our in-depth analysis of the global market includes the following segments:

         Synthetic Derivatives

  • 17 Alpha Alkyl Derivatives
  • 17 Beta Ester Derivatives

          Modes of Administration

  • Oral
  • Injection
  • Topical
  • Skin Patches
  • Inhalers


  • Anaemia
  • Breast Cancer
  • Hypogonadism


  • Oxymetholone
  • Methyltestosterone
  • Testosterone


  • Prescription Drugs
  • Over-The-Counter Drugs


  • Anabolic
  • Androgenic

          Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Anabolic Steroids Industry - Regional Synopsis

North American Market Forecast

Anabolic steroids market in North America region is attributed to hold largest revenue share of about 33% during the forecast period. The market for anabolic steroids is anticipated to be dominated by North America due to the region's increasing incidence of breast cancer and increased healthcare spending, which will also accelerate the market's growth pace. There will be roughly 310,720 new instances of invasive breast cancer detected in females. There will be roughly 56,500 new diagnoses of ductal carcinoma in situ (DCIS). There will be 42,250 female breast cancer deaths. Moreover, the anabolic steroids market growth rate in this region will also be accelerated by the expanding presence of significant key players and the increased use of innovative technologies.

APAC Market Statistics

Anabolic steroids market in Asia Pacific region is projected to hold second largest revenue share of about 30% during the forecast period.  The region's rising level of disposable income is the reason behind the expansion of the anabolic steroid business there. Additionally, the expansion of the healthcare sector and the growing number of generic medicine manufacturers will accelerate the growth rate of this industry. In 2018, more than 90% of the Indian pharmaceutical industry was made up of generic medications. In contrast, generics made up just about 29% of the Taiwanese pharmaceutical industry that year.

Research Nester
Anabolic Steroids Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Anabolic Steroids Landscape

    • Mylan N.V.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Johnson & Johnson Private Limited
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy’s Laboratories Ltd.
    • Merck & Co., Inc.


In The News

  • April 2019: Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced the introduction of AndroGel ®i 1.62% CIII as a generic drug in the United States. For the treatment of disorders related to a lack of endogenous testosterone in adult males, such as primary hypogonadism and hypogonadotropic hypogonadism, testosterone Gel 1.62% CIII is recommended. Teva is the market leader in first-to-file opportunities, with over 100 pending first-to-files in the United States, and has the largest portfolio of FDA-approved generic drugs, with approximately 500 generic medications available. Teva generic products are currently used to fill one in every eight generic prescriptions that are written in the United States.
  • December 2022: Pfizer Inc. reported that a New Drug Application (NDA) for etrasimod for people with moderately-to-severely active ulcerative colitis (UC) has been accepted for consideration by the U.S. Food and Drug Administration (FDA). The FDA's choice is anticipated in 2023's second half. The Marketing Authorization Application (MAA) for etrasimod in the same patient population has also been accepted by the European Medicines Agency (EMA), and a decision is expected in the first half of 2024.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5986
  • Published Date: Apr 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing geriatric population and prevalence of hypogonadism in men are the major factors driving the growth of the anabolic steroids market.

The market size of anabolic steroids is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2024-2036.

The major players in the market are F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc., and others.

The injection segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Anabolic Steroids Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying